News World Fujifilm says COVID-19 drug research may drag on into July

Fujifilm says COVID-19 drug research may drag on into July

 

Fujifilm Holdings Corp’s research on Avigan, also known as Favipiravir. as a potential treatment for COVID-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm’s race to prove the drug’s effectiveness against the virus.

“There is a possibility that clinical trials will continue in July,” a Fujifilm spokesman said, responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials.

After the government of Prime Minister Shinzo Abe gave up on getting approval for the drug by the end of May, the aim was to complete clinical trials this month.

But researchers have only been able to get around 70% of the patients needed for the trials, and because it takes 28 days to get results, the process will continue until at least July, the Nikkei business daily said, citing an unnamed source.

The spokesman said Fujifilm does not make public details of the progress of clinical trials but it has expanded the number of medical institutions that are cooperate in the trials. “We aim to complete clinical trials as soon as possible.”

Drugmakers around the world are scrambling to develop a vaccine for the new coronavirus, which has infected nearly 7 million people globally, while the disease it causes, COVID-19, has killed nearly 400,000.

Many countries are focusing on drugs like Gilead Sciences Inc’s antiviral remdesivir and some are using the anti-malaria drug hydroxychloroquine, touted by U.S. President Donald Trump. Abe’s government has championed Japanese candidate Avigan, also known as Favipiravir.

Countries that have succeeded in curbing infections have sometimes paradoxically found it difficult to sustain clinical trials because of dwindling sample sizes for patients.

Japan has avoided the explosive outbreaks seen in some other nations, with about 17,000 infections, and the number of daily infection has been falling, according to public broadcaster NHK and the health ministry.

(Reuters)

Top Stories

EU, Turkey cautiously eye improved ties after tough 2020

The European Union and Turkey have pressed each other to take concrete steps to improve relations long strained by disagreements over energy, migration and...

TV audience for Biden inauguration tops Trump’s viewership four years earlier

Roughly 40 million people watched live coverage of Democrat Joe Biden's inauguration as U.S. president on six TV networks, according to Nielsen data released...

EU to tighten travel curbs for virus hot spots as third wave fears mount

The European Commission has proposed to EU leaders identifying "dark red" coronavirus hot spots from which all but essential travel would be discouraged after...

President Anastasiades says slow rollout of EU vaccines a problem

President Nicos Anastasiades has pointed out the problems Cyprus is confronted with because of the slow rollout from the EU of Covid-19 vaccines. This is...

Cyprus’ revised 2021 budget approved by marginal majority

Cyprus’ revised 2021 budget was approved by marginal majority on Thursday evening allowing the government to deal with the crucial economic fallout from the...

Taste

Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...

Mezedes

No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...